0.02 | 0.42%
| Price and Volume | |
|---|---|
| Recent Price | 4.78 |
| 52 Week High | 5.85 |
| 52 Week Low | 3.15 |
| Avg. Daily Vol. (Mil) | 1.58 |
| Beta (3 year) | 1.04 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,410.71 |
| Shares Out (Mil) | 295.13 |
| Float (Mil) | 136.79 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.60 |
| Current Ratio | 3.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.09 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 44.76 |
| Price/Book | 9.10 |
| Price/Cash Flow | 5.30K |
| Per Share Data | |
| Earnings | -0.02 |
| Sales | 0.11 |
| Book Value | 0.53 |
| Cash Flow | 0.00 |
| Business Summary | |
|---|---|
| OPKO Health, Inc. is engaged in the development and commercialization of pharmaceutical products, vaccines, diagnostic technologies, and imaging systems. | |
| General Information | |
| 4400 Biscayne Boulevard
Miami, FL 33137 |
|
| www.opko.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 268 | |
| CEO: Dr. Phillip Frost,M.D. | |
| Short Interest | |
| Current Month (Mil) | 33.03 |
| Previous Month (Mil) | 32.68 |
| Short Interest Ratio (Days) | 23.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -1.10 |
| Return on Investments | -1.70 |
| Profitability | |
| Gross Margin | 39.90 |
| EBIT Margin | -91.20 |
| Profit Margin | -8.30 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,580.69 | 1,332.42 | 2,870.99 | 17.31 |
Oil *
106.79
|
|
UP
125.86 |
UP
14.60 |
UP
33.46 |
DOWN
0.14 |
10 Yr
1.73%
SPDR Gold
151.02
|
|
+1.01%
|
+1.11%
|
+1.18%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet